1982P Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC).

Saved in:
Bibliographic Details
Title: 1982P Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC).
Authors: Perez Valderrama, B.1 (AUTHOR), Garcia Del Muro, X.2 (AUTHOR), Merseburger, A.S.3 (AUTHOR), Loriot, Y.4 (AUTHOR), Choy, E.5 (AUTHOR), Castellano Gauna, D.E.6 (AUTHOR), Lopez-Rios, F.7 (AUTHOR), Bonfill Abella, T.8 (AUTHOR), Montesa Pino, A.9 (AUTHOR), Yu, P.10 (AUTHOR), Skamnioti, P.11 (AUTHOR), Sternberg, C.N.12 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1146-S1147. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.2067